online oral semaglutide Thinly — Physician-supervised weight care, Oral Semaglutide Approved to Reduce

Manufacturers are seeking to improve efficacy by developing new dual- and tri-agonists, studying combinations, and offering more potent doses

doi: 10.1016/j.ccr.2011.11.002 104 LeblancRLeeSCDavidMBordetJCNormanDDPatilRet al

Blecker C

The trial was double-blinded, meaning neither the investigators nor the persons with Parkinsons were made aware of who was actually receiving an active drug (rather than a placebo/inactive drug)

While beneficial for normal growth, it poses a theoretical risk of accelerating the growth of existing or dormant cancers (for example, prostate, breast, colon) by inhibiting apoptosis (programmed cell death) and driving cell replication

Cons: Less effective for significant weight loss compared to Semaglutide or Tirzepatide